Intracellular targeting of endogenous proteins
US6004940A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Dec 6, 1994 |
| Grant date | Dec 21, 1999 |
| Priority date | — |
| Expiry date | Dec 6, 2014 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method by which one can target an undesired target molecule or target antigen, preferably an endogenous protein. The method comprises the intracellular expression of an antibody capable of binding to the target. A DNA sequence is delivered to a cell, the DNA sequence contains a sufficient number of nucleotides coding for the portion of an antibody capable of binding to the target operably linked to a promoter that will permit expression of the antibody in the cell(s) of interest. The antibody is then expressed intracellularly and binds to the target, thereby disrupting the target from its normal actions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.